Modeling pulmonary alveolar microlithiasis by epithelial deletion of the Npt2b sodium phosphate cotransporter reveals putative biomarkers and strategies for treatment.

MLA

Saito, Atsushi, et al. “Modeling Pulmonary Alveolar Microlithiasis by Epithelial Deletion of the Npt2b Sodium Phosphate Cotransporter Reveals Putative Biomarkers and Strategies for Treatment.” Science Translational Medicine, vol. 7, no. 313, Nov. 2015, p. 313ra181. EBSCOhost, https://doi.org/10.1126/scitranslmed.aac8577.

APA

Saito, A., Nikolaidis, N. M., Amlal, H., Uehara, Y., Gardner, J. C., LaSance, K., Pitstick, L. B., Bridges, J. P., Wikenheiser-Brokamp, K. A., McGraw, D. W., Woods, J. C., Sabbagh, Y., Schiavi, S. C., Altinişik, G., Jakopović, M., Inoue, Y., & McCormack, F. X. (2015). Modeling pulmonary alveolar microlithiasis by epithelial deletion of the Npt2b sodium phosphate cotransporter reveals putative biomarkers and strategies for treatment. Science Translational Medicine, 7(313), 313ra181. https://doi.org/10.1126/scitranslmed.aac8577

Chicago

Saito, Atsushi, Nikolaos M Nikolaidis, Hassane Amlal, Yasuaki Uehara, Jason C Gardner, Kathleen LaSance, Lori B Pitstick, et al. 2015. “Modeling Pulmonary Alveolar Microlithiasis by Epithelial Deletion of the Npt2b Sodium Phosphate Cotransporter Reveals Putative Biomarkers and Strategies for Treatment.” Science Translational Medicine 7 (313): 313ra181. doi:10.1126/scitranslmed.aac8577.